

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 9.03107886 |
| 2 | muscle filament sliding (GO:0030049) | 9.03107886 |
| 3 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 8.97732106 |
| 4 | rhodopsin mediated signaling pathway (GO:0016056) | 8.70866446 |
| 5 | photoreceptor cell maintenance (GO:0045494) | 8.10163555 |
| 6 | actin-mediated cell contraction (GO:0070252) | 7.63880357 |
| 7 | retinal cone cell development (GO:0046549) | 7.53715114 |
| 8 | photoreceptor cell development (GO:0042461) | 7.51581365 |
| 9 | eye photoreceptor cell development (GO:0042462) | 7.00196979 |
| 10 | retinal rod cell development (GO:0046548) | 6.93456591 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.65980544 |
| 12 | photoreceptor cell differentiation (GO:0046530) | 6.17057715 |
| 13 | eye photoreceptor cell differentiation (GO:0001754) | 6.17057715 |
| 14 | skeletal muscle contraction (GO:0003009) | 6.13917667 |
| 15 | phototransduction (GO:0007602) | 6.11856032 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 5.97837539 |
| 17 | phototransduction, visible light (GO:0007603) | 5.82516299 |
| 18 | detection of light stimulus (GO:0009583) | 5.76860488 |
| 19 | sarcomere organization (GO:0045214) | 5.63078221 |
| 20 | visual perception (GO:0007601) | 5.56534825 |
| 21 | actin filament-based movement (GO:0030048) | 5.55779376 |
| 22 | detection of visible light (GO:0009584) | 5.53568001 |
| 23 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.50904089 |
| 24 | detection of light stimulus involved in visual perception (GO:0050908) | 5.50904089 |
| 25 | sensory perception of light stimulus (GO:0050953) | 5.49541072 |
| 26 | GMP metabolic process (GO:0046037) | 5.25694025 |
| 27 | response to muscle activity (GO:0014850) | 5.14274207 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.14167162 |
| 29 | gonadal mesoderm development (GO:0007506) | 5.12084945 |
| 30 | striated muscle contraction (GO:0006941) | 4.97537054 |
| 31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.80879188 |
| 32 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.64787174 |
| 33 | retina development in camera-type eye (GO:0060041) | 4.62249479 |
| 34 | glycogen catabolic process (GO:0005980) | 4.56691958 |
| 35 | actomyosin structure organization (GO:0031032) | 4.40358764 |
| 36 | regulation of cell communication by electrical coupling (GO:0010649) | 4.30447802 |
| 37 | muscle contraction (GO:0006936) | 4.29679769 |
| 38 | skeletal muscle fiber development (GO:0048741) | 4.28284558 |
| 39 | glucan catabolic process (GO:0009251) | 4.23135120 |
| 40 | creatine metabolic process (GO:0006600) | 4.22909470 |
| 41 | protein-chromophore linkage (GO:0018298) | 4.21838930 |
| 42 | detection of external stimulus (GO:0009581) | 4.18352117 |
| 43 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.17193603 |
| 44 | regulation of actin filament-based movement (GO:1903115) | 4.15546947 |
| 45 | cardiac muscle contraction (GO:0060048) | 4.09732741 |
| 46 | myotube cell development (GO:0014904) | 4.06771962 |
| 47 | detection of abiotic stimulus (GO:0009582) | 4.04112954 |
| 48 | skeletal muscle tissue development (GO:0007519) | 4.03940706 |
| 49 | response to inactivity (GO:0014854) | 4.02048118 |
| 50 | plasma membrane repair (GO:0001778) | 3.95805934 |
| 51 | cellular polysaccharide catabolic process (GO:0044247) | 3.86487679 |
| 52 | cellular response to light stimulus (GO:0071482) | 3.85782962 |
| 53 | muscle system process (GO:0003012) | 3.83333718 |
| 54 | appendage development (GO:0048736) | 3.75172386 |
| 55 | limb development (GO:0060173) | 3.75172386 |
| 56 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.74016186 |
| 57 | muscle cell cellular homeostasis (GO:0046716) | 3.71469085 |
| 58 | regulation of guanylate cyclase activity (GO:0031282) | 3.70100015 |
| 59 | cardiac muscle hypertrophy (GO:0003300) | 3.68606379 |
| 60 | carnitine shuttle (GO:0006853) | 3.65830159 |
| 61 | skeletal muscle adaptation (GO:0043501) | 3.60453273 |
| 62 | polysaccharide catabolic process (GO:0000272) | 3.60014263 |
| 63 | muscle tissue morphogenesis (GO:0060415) | 3.57255847 |
| 64 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.57013738 |
| 65 | muscle cell fate commitment (GO:0042693) | 3.56107334 |
| 66 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.54892802 |
| 67 | muscle fiber development (GO:0048747) | 3.54045873 |
| 68 | fibroblast migration (GO:0010761) | 3.53328559 |
| 69 | striated muscle hypertrophy (GO:0014897) | 3.52672446 |
| 70 | metanephric mesenchyme development (GO:0072075) | 3.49108850 |
| 71 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.47658927 |
| 72 | regulation of cGMP metabolic process (GO:0030823) | 3.46261813 |
| 73 | glucan biosynthetic process (GO:0009250) | 3.43136086 |
| 74 | glycogen biosynthetic process (GO:0005978) | 3.43136086 |
| 75 | skeletal muscle tissue regeneration (GO:0043403) | 3.41315791 |
| 76 | lymph vessel development (GO:0001945) | 3.35462161 |
| 77 | cardiac muscle cell development (GO:0055013) | 3.33413795 |
| 78 | heart contraction (GO:0060047) | 3.31633499 |
| 79 | heart process (GO:0003015) | 3.31633499 |
| 80 | NADH metabolic process (GO:0006734) | 3.28746953 |
| 81 | response to dexamethasone (GO:0071548) | 3.24239379 |
| 82 | muscle structure development (GO:0061061) | 3.21762289 |
| 83 | muscle organ development (GO:0007517) | 3.21494721 |
| 84 | estrogen biosynthetic process (GO:0006703) | 3.21381591 |
| 85 | striated muscle adaptation (GO:0014888) | 3.20049159 |
| 86 | regulation of striated muscle contraction (GO:0006942) | 3.18835305 |
| 87 | kidney mesenchyme development (GO:0072074) | 3.17159365 |
| 88 | positive regulation of gastrulation (GO:2000543) | 3.16346332 |
| 89 | muscle organ morphogenesis (GO:0048644) | 3.15822179 |
| 90 | glycogen metabolic process (GO:0005977) | 3.14196514 |
| 91 | striated muscle cell development (GO:0055002) | 3.13956568 |
| 92 | notochord development (GO:0030903) | 3.13526138 |
| 93 | fatty acid transmembrane transport (GO:1902001) | 3.11188333 |
| 94 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.10765577 |
| 95 | cardiac cell development (GO:0055006) | 3.10145123 |
| 96 | regulation of sequestering of triglyceride (GO:0010889) | 3.09900552 |
| 97 | muscle hypertrophy (GO:0014896) | 3.07973518 |
| 98 | cellular glucan metabolic process (GO:0006073) | 3.05945106 |
| 99 | glucan metabolic process (GO:0044042) | 3.05945106 |
| 100 | adult heart development (GO:0007512) | 3.03703652 |
| 101 | cardiac myofibril assembly (GO:0055003) | 2.99406207 |
| 102 | response to epinephrine (GO:0071871) | 2.97627793 |
| 103 | response to activity (GO:0014823) | 2.97003237 |
| 104 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.96132320 |
| 105 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.95183502 |
| 106 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.95122657 |
| 107 | striated muscle tissue development (GO:0014706) | 2.94878441 |
| 108 | cell migration involved in heart development (GO:0060973) | 2.94543266 |
| 109 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.94281532 |
| 110 | negative regulation of protein localization to cell surface (GO:2000009) | 2.93710219 |
| 111 | positive regulation of odontogenesis (GO:0042482) | 2.91966778 |
| 112 | carnitine transmembrane transport (GO:1902603) | 2.91839380 |
| 113 | nonmotile primary cilium assembly (GO:0035058) | 2.87928525 |
| 114 | positive regulation of cGMP metabolic process (GO:0030825) | 2.86065003 |
| 115 | muscle cell development (GO:0055001) | 2.82912863 |
| 116 | endocardial cushion morphogenesis (GO:0003203) | 2.82343900 |
| 117 | tricarboxylic acid cycle (GO:0006099) | 2.81972001 |
| 118 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.81657210 |
| 119 | positive regulation of catecholamine secretion (GO:0033605) | 2.81469724 |
| 120 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.80247263 |
| 121 | muscle hypertrophy in response to stress (GO:0003299) | 2.80247263 |
| 122 | cardiac muscle adaptation (GO:0014887) | 2.80247263 |
| 123 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.77924996 |
| 124 | muscle tissue development (GO:0060537) | 2.77637170 |
| 125 | paraxial mesoderm development (GO:0048339) | 2.76644987 |
| 126 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.75773485 |
| 127 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75717647 |
| 128 | myoblast fusion (GO:0007520) | 2.73676543 |
| 129 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.73451348 |
| 130 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.71917948 |
| 131 | positive regulation of myotube differentiation (GO:0010831) | 2.71901688 |
| 132 | cellular response to epinephrine stimulus (GO:0071872) | 2.70008266 |
| 133 | carnitine transport (GO:0015879) | 2.69299297 |
| 134 | amino-acid betaine transport (GO:0015838) | 2.69299297 |
| 135 | regulation of myoblast differentiation (GO:0045661) | 2.68652423 |
| 136 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.68541189 |
| 137 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.68016625 |
| 138 | retina layer formation (GO:0010842) | 2.66165563 |
| 139 | glomerulus development (GO:0032835) | 2.65468530 |
| 140 | embryonic foregut morphogenesis (GO:0048617) | 2.65452415 |
| 141 | cGMP-mediated signaling (GO:0019934) | 2.65300663 |
| 142 | midgut development (GO:0007494) | 2.61813818 |
| 143 | regulation of cGMP biosynthetic process (GO:0030826) | 2.60407595 |
| 144 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.59338287 |
| 145 | epithelial cell fate commitment (GO:0072148) | 2.56028739 |
| 146 | lipid particle organization (GO:0034389) | 2.55360936 |
| 147 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.55270754 |
| 148 | sensory perception (GO:0007600) | 2.53251327 |
| 149 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.51997905 |
| 150 | endocardial cushion development (GO:0003197) | 2.49630067 |
| 151 | mesenchyme morphogenesis (GO:0072132) | 2.45544141 |
| 152 | myelination in peripheral nervous system (GO:0022011) | 2.45460866 |
| 153 | peripheral nervous system axon ensheathment (GO:0032292) | 2.45460866 |
| 154 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.45339031 |
| 155 | plasma membrane fusion (GO:0045026) | 2.44639903 |
| 156 | myofibril assembly (GO:0030239) | 2.44074022 |
| 157 | surfactant homeostasis (GO:0043129) | 2.42644966 |
| 158 | protein heterotrimerization (GO:0070208) | 2.42051940 |
| 159 | regulation of cardioblast differentiation (GO:0051890) | 2.39311671 |
| 160 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.38050129 |
| 161 | regulation of skeletal muscle contraction (GO:0014819) | 2.37398563 |
| 162 | sex determination (GO:0007530) | 2.36618887 |
| 163 | cellular response to radiation (GO:0071478) | 2.36600931 |
| 164 | glomerular filtration (GO:0003094) | 2.35235823 |
| 165 | Leydig cell differentiation (GO:0033327) | 2.34698544 |
| 166 | regulation of axon guidance (GO:1902667) | 2.33076923 |
| 167 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.32616971 |
| 168 | potassium ion import (GO:0010107) | 2.31656140 |
| 169 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.30861380 |
| 170 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.30460224 |
| 171 | lung vasculature development (GO:0060426) | 2.29372080 |
| 172 | neuron development (GO:0048666) | 2.26548224 |
| 173 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.26354841 |
| 174 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.25742587 |
| 175 | axoneme assembly (GO:0035082) | 2.24465682 |
| 176 | camera-type eye morphogenesis (GO:0048593) | 2.23640016 |
| 177 | hippo signaling (GO:0035329) | 2.23198141 |
| 178 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.23022895 |
| 179 | vasculature development (GO:0001944) | 2.21521653 |
| 180 | motile cilium assembly (GO:0044458) | 2.19605534 |
| 181 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.19379775 |
| 182 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.18596282 |
| 183 | piRNA metabolic process (GO:0034587) | 2.18529771 |
| 184 | aorta morphogenesis (GO:0035909) | 2.16798773 |
| 185 | renal filtration (GO:0097205) | 2.15597944 |
| 186 | neuron remodeling (GO:0016322) | 2.14980909 |
| 187 | blood vessel maturation (GO:0001955) | 2.13738131 |
| 188 | response to light stimulus (GO:0009416) | 2.13538091 |
| 189 | negative regulation of catenin import into nucleus (GO:0035414) | 2.13436132 |
| 190 | lymphangiogenesis (GO:0001946) | 2.12029293 |
| 191 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.11348871 |
| 192 | coronary vasculature morphogenesis (GO:0060977) | 2.10019674 |
| 193 | regulation of vasculogenesis (GO:2001212) | 2.09209601 |
| 194 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.09095938 |
| 195 | dorsal/ventral axis specification (GO:0009950) | 2.08787943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.23711688 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.31339026 |
| 3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.29960415 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.07519004 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.89156280 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.86805858 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.77357098 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.70421963 |
| 9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.64520212 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.55956397 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36725075 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.28927941 |
| 13 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.24063128 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14500532 |
| 15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.09465791 |
| 16 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.93513794 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.91982297 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.91151458 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86194812 |
| 20 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.82860412 |
| 21 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74808157 |
| 22 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74808157 |
| 23 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.73970729 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.68132752 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66101012 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64582443 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.63221072 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62655367 |
| 29 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.61215080 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.59945243 |
| 31 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59399495 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58773834 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.57734892 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57305120 |
| 35 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.56682096 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56492550 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56467740 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56467740 |
| 39 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.56389290 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.55931995 |
| 41 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.53516137 |
| 42 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52313759 |
| 43 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.49305991 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47492101 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47163017 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46059617 |
| 47 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.44939697 |
| 48 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43507623 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41121297 |
| 50 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.39726982 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38212047 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37852867 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37772175 |
| 54 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.37615591 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36679075 |
| 56 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.36016653 |
| 57 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35847717 |
| 58 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.35188702 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.34051605 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33333913 |
| 61 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.32294453 |
| 62 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.31263133 |
| 63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30911234 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29545926 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29389809 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28885940 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28693816 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28354812 |
| 69 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.27451255 |
| 70 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.27090555 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26835411 |
| 72 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.26717840 |
| 73 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.26625503 |
| 74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.26107048 |
| 75 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.25569378 |
| 76 | NFYB_21822215_ChIP-Seq_K562_Human | 1.24814484 |
| 77 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.24794827 |
| 78 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24373454 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23265726 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22745757 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22690908 |
| 82 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.21642246 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21176553 |
| 84 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.19505143 |
| 85 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18102944 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18020193 |
| 87 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17824818 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17760231 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17335604 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17328915 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16982855 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16982855 |
| 93 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16948962 |
| 94 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13862326 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12980360 |
| 96 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12485300 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12293736 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12124083 |
| 99 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11118172 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.09882527 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 1.09812799 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09499544 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08518821 |
| 104 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.08516337 |
| 105 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08335310 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07972734 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07565119 |
| 108 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06382613 |
| 109 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05366748 |
| 110 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.04311217 |
| 111 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04215943 |
| 112 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03522046 |
| 113 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03418793 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03314109 |
| 115 | CBP_21632823_ChIP-Seq_H3396_Human | 1.03179110 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03132765 |
| 117 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02049832 |
| 118 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.01880742 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99967245 |
| 120 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.99288323 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99048953 |
| 122 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98340039 |
| 123 | NFYA_21822215_ChIP-Seq_K562_Human | 0.96589292 |
| 124 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96326714 |
| 125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95637065 |
| 126 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.95539878 |
| 127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94458910 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94151863 |
| 129 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93739081 |
| 130 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93204711 |
| 131 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93156081 |
| 132 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92938557 |
| 133 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.92787458 |
| 134 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92496691 |
| 135 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92047414 |
| 136 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91564247 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91262756 |
| 138 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91032873 |
| 139 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91032873 |
| 140 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90996936 |
| 141 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90534178 |
| 142 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90513172 |
| 143 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89751455 |
| 144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89602414 |
| 145 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89098123 |
| 146 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88986967 |
| 147 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88897635 |
| 148 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.88170825 |
| 149 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88101342 |
| 150 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87685993 |
| 151 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87593178 |
| 152 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87378825 |
| 153 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87323374 |
| 154 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.86501083 |
| 155 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86401607 |
| 156 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86391608 |
| 157 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86380246 |
| 158 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86232017 |
| 159 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86040323 |
| 160 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.85341844 |
| 161 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84191391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 7.24505722 |
| 2 | * MP0005551_abnormal_eye_electrophysiolog | 6.52055668 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 5.36665939 |
| 4 | * MP0005253_abnormal_eye_physiology | 4.71916093 |
| 5 | * MP0005195_abnormal_posterior_eye | 3.02905006 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.65548297 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.61603215 |
| 8 | * MP0005391_vision/eye_phenotype | 2.58662507 |
| 9 | MP0001324_abnormal_eye_pigmentation | 2.57517175 |
| 10 | MP0004272_abnormal_basement_membrane | 2.56928577 |
| 11 | MP0002269_muscular_atrophy | 2.49729559 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.38985640 |
| 13 | MP0000751_myopathy | 2.31376806 |
| 14 | MP0005670_abnormal_white_adipose | 2.26328888 |
| 15 | MP0005623_abnormal_meninges_morphology | 2.01860585 |
| 16 | MP0001879_abnormal_lymphatic_vessel | 1.89402864 |
| 17 | MP0005503_abnormal_tendon_morphology | 1.81335115 |
| 18 | MP0002090_abnormal_vision | 1.74399933 |
| 19 | MP0004084_abnormal_cardiac_muscle | 1.72157887 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.67494770 |
| 21 | MP0010030_abnormal_orbit_morphology | 1.63381920 |
| 22 | MP0005275_abnormal_skin_tensile | 1.58034509 |
| 23 | MP0004036_abnormal_muscle_relaxation | 1.57079380 |
| 24 | MP0002127_abnormal_cardiovascular_syste | 1.56672522 |
| 25 | MP0004233_abnormal_muscle_weight | 1.54728994 |
| 26 | MP0002229_neurodegeneration | 1.53166596 |
| 27 | MP0005451_abnormal_body_composition | 1.50620903 |
| 28 | MP0005410_abnormal_fertilization | 1.49487951 |
| 29 | MP0001958_emphysema | 1.48142967 |
| 30 | * MP0002752_abnormal_somatic_nervous | 1.43197233 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.42106000 |
| 32 | MP0002234_abnormal_pharynx_morphology | 1.40318825 |
| 33 | MP0002971_abnormal_brown_adipose | 1.39620835 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.32993515 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.31984812 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.29260763 |
| 37 | MP0004484_altered_response_of | 1.27861602 |
| 38 | MP0009384_cardiac_valve_regurgitation | 1.24116653 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.23534239 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.21475362 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.17358439 |
| 42 | MP0004885_abnormal_endolymph | 1.15931893 |
| 43 | MP0005187_abnormal_penis_morphology | 1.14309983 |
| 44 | MP0005248_abnormal_Harderian_gland | 1.11806457 |
| 45 | MP0000534_abnormal_ureter_morphology | 1.11670232 |
| 46 | MP0008995_early_reproductive_senescence | 1.11186575 |
| 47 | MP0000762_abnormal_tongue_morphology | 1.09644253 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.09480743 |
| 49 | MP0002822_catalepsy | 1.05132886 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.04377692 |
| 51 | MP0001293_anophthalmia | 1.03454191 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.01652454 |
| 53 | MP0003942_abnormal_urinary_system | 1.01045312 |
| 54 | MP0002697_abnormal_eye_size | 0.99511048 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 0.98815402 |
| 56 | MP0006138_congestive_heart_failure | 0.98501977 |
| 57 | MP0003385_abnormal_body_wall | 0.97535469 |
| 58 | MP0000767_abnormal_smooth_muscle | 0.97250042 |
| 59 | MP0003122_maternal_imprinting | 0.97195124 |
| 60 | MP0000749_muscle_degeneration | 0.96384750 |
| 61 | MP0005330_cardiomyopathy | 0.95460589 |
| 62 | * MP0002882_abnormal_neuron_morphology | 0.93301655 |
| 63 | MP0010630_abnormal_cardiac_muscle | 0.93009827 |
| 64 | MP0003115_abnormal_respiratory_system | 0.92654436 |
| 65 | MP0005083_abnormal_biliary_tract | 0.92628260 |
| 66 | MP0005266_abnormal_metabolism | 0.92090633 |
| 67 | MP0000733_abnormal_muscle_development | 0.91879147 |
| 68 | MP0000537_abnormal_urethra_morphology | 0.90443487 |
| 69 | MP0002282_abnormal_trachea_morphology | 0.89304516 |
| 70 | MP0003828_pulmonary_edema | 0.89068398 |
| 71 | MP0003045_fibrosis | 0.87315990 |
| 72 | MP0003646_muscle_fatigue | 0.86828494 |
| 73 | MP0003137_abnormal_impulse_conducting | 0.84756601 |
| 74 | MP0000003_abnormal_adipose_tissue | 0.84468732 |
| 75 | MP0005197_abnormal_uvea_morphology | 0.84345823 |
| 76 | MP0000428_abnormal_craniofacial_morphol | 0.83854522 |
| 77 | MP0005369_muscle_phenotype | 0.83789541 |
| 78 | MP0000750_abnormal_muscle_regeneration | 0.83428078 |
| 79 | MP0000462_abnormal_digestive_system | 0.83079994 |
| 80 | MP0000759_abnormal_skeletal_muscle | 0.82724743 |
| 81 | MP0002106_abnormal_muscle_physiology | 0.82605807 |
| 82 | MP0003935_abnormal_craniofacial_develop | 0.81305518 |
| 83 | MP0002972_abnormal_cardiac_muscle | 0.79522862 |
| 84 | MP0008789_abnormal_olfactory_epithelium | 0.78653590 |
| 85 | MP0004085_abnormal_heartbeat | 0.78050271 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 0.76550987 |
| 87 | MP0001286_abnormal_eye_development | 0.76303756 |
| 88 | MP0003279_aneurysm | 0.76186825 |
| 89 | MP0000266_abnormal_heart_morphology | 0.75743129 |
| 90 | MP0003634_abnormal_glial_cell | 0.75676263 |
| 91 | MP0001346_abnormal_lacrimal_gland | 0.75598244 |
| 92 | MP0003119_abnormal_digestive_system | 0.75214945 |
| 93 | MP0003890_abnormal_embryonic-extraembry | 0.75156324 |
| 94 | MP0009250_abnormal_appendicular_skeleto | 0.74658363 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.74654389 |
| 96 | MP0004130_abnormal_muscle_cell | 0.73634033 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.72997094 |
| 98 | MP0002925_abnormal_cardiovascular_devel | 0.69861898 |
| 99 | MP0001614_abnormal_blood_vessel | 0.69624444 |
| 100 | MP0003698_abnormal_male_reproductive | 0.68575665 |
| 101 | MP0000747_muscle_weakness | 0.67544405 |
| 102 | MP0002938_white_spotting | 0.66678201 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66677570 |
| 104 | MP0001544_abnormal_cardiovascular_syste | 0.66475837 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.66475837 |
| 106 | MP0004510_myositis | 0.66143804 |
| 107 | MP0002114_abnormal_axial_skeleton | 0.64938358 |
| 108 | MP0005394_taste/olfaction_phenotype | 0.64873569 |
| 109 | MP0005499_abnormal_olfactory_system | 0.64873569 |
| 110 | MP0001661_extended_life_span | 0.64024073 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.63748714 |
| 112 | MP0003959_abnormal_lean_body | 0.63401428 |
| 113 | MP0000049_abnormal_middle_ear | 0.63044573 |
| 114 | MP0002092_abnormal_eye_morphology | 0.62985936 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.62892594 |
| 116 | MP0003283_abnormal_digestive_organ | 0.62320743 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.62245949 |
| 118 | MP0002128_abnormal_blood_circulation | 0.62198624 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.61818356 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.61393568 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.61265822 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.60913839 |
| 123 | MP0002168_other_aberrant_phenotype | 0.60359208 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.58306658 |
| 125 | MP0009115_abnormal_fat_cell | 0.54838120 |
| 126 | MP0003755_abnormal_palate_morphology | 0.53375044 |
| 127 | MP0002932_abnormal_joint_morphology | 0.51144914 |
| 128 | MP0005165_increased_susceptibility_to | 0.50535525 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.49337017 |
| 130 | MP0003879_abnormal_hair_cell | 0.48876982 |
| 131 | MP0005409_darkened_coat_color | 0.48429874 |
| 132 | MP0003136_yellow_coat_color | 0.47595533 |
| 133 | MP0005508_abnormal_skeleton_morphology | 0.47343887 |
| 134 | MP0002233_abnormal_nose_morphology | 0.46314538 |
| 135 | MP0002876_abnormal_thyroid_physiology | 0.44804406 |
| 136 | MP0009697_abnormal_copulation | 0.44754890 |
| 137 | MP0005647_abnormal_sex_gland | 0.43804336 |
| 138 | MP0003941_abnormal_skin_development | 0.43462577 |
| 139 | MP0003984_embryonic_growth_retardation | 0.41728074 |
| 140 | MP0002088_abnormal_embryonic_growth/wei | 0.41532000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 8.90221958 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 8.68819284 |
| 3 | Nemaline bodies (HP:0003798) | 8.61272839 |
| 4 | Congenital stationary night blindness (HP:0007642) | 8.51081026 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.47575201 |
| 6 | Chorioretinal atrophy (HP:0000533) | 8.31137363 |
| 7 | Bony spicule pigmentary retinopathy (HP:0007737) | 8.05907206 |
| 8 | Abnormal rod and cone electroretinograms (HP:0008323) | 7.92239020 |
| 9 | Pigmentary retinal degeneration (HP:0001146) | 7.81063683 |
| 10 | Central scotoma (HP:0000603) | 7.55220512 |
| 11 | Abolished electroretinogram (ERG) (HP:0000550) | 7.16761499 |
| 12 | Pendular nystagmus (HP:0012043) | 7.09214732 |
| 13 | Scotoma (HP:0000575) | 6.69574564 |
| 14 | Dyschromatopsia (HP:0007641) | 6.53660631 |
| 15 | Posterior subcapsular cataract (HP:0007787) | 6.29710314 |
| 16 | Abnormality of macular pigmentation (HP:0008002) | 6.19229981 |
| 17 | Vitreoretinal degeneration (HP:0000655) | 5.54426761 |
| 18 | Distal arthrogryposis (HP:0005684) | 5.52495802 |
| 19 | Calcaneovalgus deformity (HP:0001848) | 4.88190650 |
| 20 | Decreased central vision (HP:0007663) | 4.82203241 |
| 21 | Increased corneal curvature (HP:0100692) | 4.66045803 |
| 22 | Keratoconus (HP:0000563) | 4.66045803 |
| 23 | Type II diabetes mellitus (HP:0005978) | 4.65400735 |
| 24 | Round ear (HP:0100830) | 4.60794016 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 4.54752311 |
| 26 | Macular degeneration (HP:0000608) | 4.52976731 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 4.45970338 |
| 28 | Cone-rod dystrophy (HP:0000548) | 4.40776301 |
| 29 | Myopathic facies (HP:0002058) | 4.32992831 |
| 30 | Deformed tarsal bones (HP:0008119) | 4.30101083 |
| 31 | Rhabdomyolysis (HP:0003201) | 4.23255788 |
| 32 | Myoglobinuria (HP:0002913) | 4.19544296 |
| 33 | Subcapsular cataract (HP:0000523) | 4.16105293 |
| 34 | Photophobia (HP:0000613) | 3.99304781 |
| 35 | Neck muscle weakness (HP:0000467) | 3.95160661 |
| 36 | Rimmed vacuoles (HP:0003805) | 3.87642727 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.84896266 |
| 38 | Severe visual impairment (HP:0001141) | 3.79906635 |
| 39 | Ulnar deviation of the wrist (HP:0003049) | 3.68463954 |
| 40 | Constricted visual fields (HP:0001133) | 3.61461755 |
| 41 | Subaortic stenosis (HP:0001682) | 3.52529086 |
| 42 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.52529086 |
| 43 | Absent phalangeal crease (HP:0006109) | 3.49720544 |
| 44 | Muscle stiffness (HP:0003552) | 3.16257610 |
| 45 | Myotonia (HP:0002486) | 3.15907231 |
| 46 | Choroideremia (HP:0001139) | 3.13835836 |
| 47 | Asymmetric septal hypertrophy (HP:0001670) | 3.10008746 |
| 48 | Malignant hyperthermia (HP:0002047) | 3.05178801 |
| 49 | Retinitis pigmentosa (HP:0000510) | 3.04787527 |
| 50 | Areflexia of lower limbs (HP:0002522) | 3.03258426 |
| 51 | Abnormal finger flexion creases (HP:0006143) | 2.93682313 |
| 52 | Abnormality of the calcaneus (HP:0008364) | 2.91509242 |
| 53 | Lipoatrophy (HP:0100578) | 2.87816908 |
| 54 | Progressive visual loss (HP:0000529) | 2.85438566 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.85281550 |
| 56 | Bundle branch block (HP:0011710) | 2.75098776 |
| 57 | Scapular winging (HP:0003691) | 2.74515126 |
| 58 | Weak cry (HP:0001612) | 2.74055581 |
| 59 | Popliteal pterygium (HP:0009756) | 2.66382545 |
| 60 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.64241992 |
| 61 | Dilated cardiomyopathy (HP:0001644) | 2.63036489 |
| 62 | Ventricular tachycardia (HP:0004756) | 2.52428293 |
| 63 | Frequent falls (HP:0002359) | 2.52029423 |
| 64 | Gowers sign (HP:0003391) | 2.51971514 |
| 65 | Bulbar palsy (HP:0001283) | 2.42769943 |
| 66 | Abnormality of the neuromuscular junction (HP:0003398) | 2.41736397 |
| 67 | Fatigable weakness (HP:0003473) | 2.41736397 |
| 68 | Generalized muscle weakness (HP:0003324) | 2.40208296 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.35804758 |
| 70 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.30917990 |
| 71 | Type 1 muscle fiber predominance (HP:0003803) | 2.30616482 |
| 72 | Limb-girdle muscle atrophy (HP:0003797) | 2.27427106 |
| 73 | Polar cataract (HP:0010696) | 2.24258836 |
| 74 | Hip contracture (HP:0003273) | 2.24000219 |
| 75 | EMG: neuropathic changes (HP:0003445) | 2.19034572 |
| 76 | Wide nasal bridge (HP:0000431) | 2.14365696 |
| 77 | Ankle contracture (HP:0006466) | 2.13675888 |
| 78 | Progressive muscle weakness (HP:0003323) | 2.10587800 |
| 79 | Proximal amyotrophy (HP:0007126) | 2.02348951 |
| 80 | Heart block (HP:0012722) | 2.02296180 |
| 81 | Atrial fibrillation (HP:0005110) | 1.99293947 |
| 82 | Metatarsus adductus (HP:0001840) | 1.98446478 |
| 83 | Muscular dystrophy (HP:0003560) | 1.97011580 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 1.96644840 |
| 85 | Congenital sensorineural hearing impairment (HP:0008527) | 1.90888048 |
| 86 | Aortic aneurysm (HP:0004942) | 1.90722878 |
| 87 | Retinal atrophy (HP:0001105) | 1.90663625 |
| 88 | Limited hip movement (HP:0008800) | 1.89996097 |
| 89 | Short palpebral fissure (HP:0012745) | 1.89930249 |
| 90 | Severe Myopia (HP:0011003) | 1.89901175 |
| 91 | Long clavicles (HP:0000890) | 1.88517198 |
| 92 | Broad metatarsal (HP:0001783) | 1.87959076 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 1.87686518 |
| 94 | Bell-shaped thorax (HP:0001591) | 1.87328040 |
| 95 | Type 2 muscle fiber atrophy (HP:0003554) | 1.85540227 |
| 96 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84347467 |
| 97 | Difficulty climbing stairs (HP:0003551) | 1.83621775 |
| 98 | Limb-girdle muscle weakness (HP:0003325) | 1.82473987 |
| 99 | Atrioventricular block (HP:0001678) | 1.82224355 |
| 100 | Abnormality of the foot musculature (HP:0001436) | 1.78035457 |
| 101 | Midline defect of the nose (HP:0004122) | 1.76718474 |
| 102 | Bladder diverticulum (HP:0000015) | 1.74045107 |
| 103 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.73140862 |
| 104 | Right ventricular cardiomyopathy (HP:0011663) | 1.72453126 |
| 105 | Primary atrial arrhythmia (HP:0001692) | 1.71704543 |
| 106 | Supraventricular arrhythmia (HP:0005115) | 1.68397404 |
| 107 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67609416 |
| 108 | Exercise-induced muscle cramps (HP:0003710) | 1.67485829 |
| 109 | Hypoventilation (HP:0002791) | 1.67406644 |
| 110 | Supraventricular tachycardia (HP:0004755) | 1.67332771 |
| 111 | Foot dorsiflexor weakness (HP:0009027) | 1.66781472 |
| 112 | Waddling gait (HP:0002515) | 1.66494643 |
| 113 | Difficulty running (HP:0009046) | 1.66189845 |
| 114 | Cerebral aneurysm (HP:0004944) | 1.65068552 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 1.64617899 |
| 116 | Male infertility (HP:0003251) | 1.64110655 |
| 117 | Amniotic constriction ring (HP:0009775) | 1.63844048 |
| 118 | Abnormality of placental membranes (HP:0011409) | 1.63844048 |
| 119 | Muscle fiber atrophy (HP:0100295) | 1.62769309 |
| 120 | Hyperkalemia (HP:0002153) | 1.59350017 |
| 121 | Spinal rigidity (HP:0003306) | 1.59312603 |
| 122 | Pulmonary artery stenosis (HP:0004415) | 1.58976945 |
| 123 | Aortic dissection (HP:0002647) | 1.58892507 |
| 124 | Abnormality of dentin (HP:0010299) | 1.58164471 |
| 125 | Ventricular arrhythmia (HP:0004308) | 1.57088194 |
| 126 | Optic disc pallor (HP:0000543) | 1.54366812 |
| 127 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.54329198 |
| 128 | Absent/shortened dynein arms (HP:0200106) | 1.54329198 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.53114493 |
| 130 | Follicular hyperkeratosis (HP:0007502) | 1.51628664 |
| 131 | Congenital primary aphakia (HP:0007707) | 1.51482508 |
| 132 | Gait imbalance (HP:0002141) | 1.50936745 |
| 133 | Exercise-induced myalgia (HP:0003738) | 1.49457775 |
| 134 | Protrusio acetabuli (HP:0003179) | 1.46898922 |
| 135 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.45991220 |
| 136 | Renal duplication (HP:0000075) | 1.45787944 |
| 137 | Calf muscle hypertrophy (HP:0008981) | 1.45627113 |
| 138 | Increased connective tissue (HP:0009025) | 1.44792380 |
| 139 | Abnormality of the calf musculature (HP:0001430) | 1.42232602 |
| 140 | Renovascular hypertension (HP:0100817) | 1.40109640 |
| 141 | Medial flaring of the eyebrow (HP:0010747) | 1.39948608 |
| 142 | Hyporeflexia of lower limbs (HP:0002600) | 1.38516704 |
| 143 | Lymphangioma (HP:0100764) | 1.38241137 |
| 144 | Short 4th metacarpal (HP:0010044) | 1.37288428 |
| 145 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.37288428 |
| 146 | Muscle fiber splitting (HP:0003555) | 1.36555969 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.35083403 |
| 148 | Sclerocornea (HP:0000647) | 1.34066304 |
| 149 | Anophthalmia (HP:0000528) | 1.33565714 |
| 150 | Vaginal atresia (HP:0000148) | 1.33512952 |
| 151 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.31467788 |
| 152 | Rectal prolapse (HP:0002035) | 1.31284830 |
| 153 | Retinal detachment (HP:0000541) | 1.31121874 |
| 154 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.29958536 |
| 155 | Cystic liver disease (HP:0006706) | 1.29584459 |
| 156 | Genital tract atresia (HP:0001827) | 1.28848493 |
| 157 | Hypoplastic ischia (HP:0003175) | 1.24758499 |
| 158 | Prolonged QT interval (HP:0001657) | 1.24397934 |
| 159 | Nephrogenic diabetes insipidus (HP:0009806) | 1.24162607 |
| 160 | Infertility (HP:0000789) | 1.22228350 |
| 161 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.21132642 |
| 162 | Hematochezia (HP:0002573) | 1.17982088 |
| 163 | Abnormality of the parathyroid morphology (HP:0011766) | 1.17533057 |
| 164 | Joint laxity (HP:0001388) | 1.17052243 |
| 165 | Abnormality of the 4th metacarpal (HP:0010012) | 1.16566864 |
| 166 | Male pseudohermaphroditism (HP:0000037) | 1.15293155 |
| 167 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.15288106 |
| 168 | Chronic bronchitis (HP:0004469) | 1.14671265 |
| 169 | Left ventricular hypertrophy (HP:0001712) | 1.14572043 |
| 170 | Abnormality of the ischium (HP:0003174) | 1.14518006 |
| 171 | Elfin facies (HP:0004428) | 1.14352716 |
| 172 | Slender build (HP:0001533) | 1.13003615 |
| 173 | Insomnia (HP:0100785) | 1.12570059 |
| 174 | Sudden death (HP:0001699) | 1.12472027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 4.68328876 |
| 2 | ICK | 2.95394167 |
| 3 | MUSK | 2.92048189 |
| 4 | IRAK2 | 2.82522581 |
| 5 | LATS1 | 2.77152518 |
| 6 | MYLK | 2.59151630 |
| 7 | TTN | 2.38172483 |
| 8 | TIE1 | 2.38144178 |
| 9 | PIK3CG | 2.35742701 |
| 10 | MAP3K10 | 2.34681561 |
| 11 | PRKD3 | 2.33461074 |
| 12 | PDK4 | 2.14321714 |
| 13 | PDK3 | 2.14321714 |
| 14 | PDGFRA | 2.07860481 |
| 15 | CAMK1G | 2.06180604 |
| 16 | EPHB2 | 1.94149910 |
| 17 | STK39 | 1.93515172 |
| 18 | WNK4 | 1.84496926 |
| 19 | TYRO3 | 1.83920992 |
| 20 | NEK1 | 1.69798211 |
| 21 | PINK1 | 1.61798425 |
| 22 | PHKG1 | 1.60179127 |
| 23 | PHKG2 | 1.60179127 |
| 24 | TRIB3 | 1.59324275 |
| 25 | EEF2K | 1.58424654 |
| 26 | PTK2B | 1.57113461 |
| 27 | CAMK1D | 1.51849301 |
| 28 | TRPM7 | 1.46923266 |
| 29 | MST1R | 1.44910296 |
| 30 | RIPK1 | 1.42946880 |
| 31 | WNK1 | 1.41051924 |
| 32 | PDK2 | 1.40187740 |
| 33 | MAPKAPK3 | 1.38133819 |
| 34 | DMPK | 1.34779626 |
| 35 | OBSCN | 1.30523532 |
| 36 | FGFR2 | 1.24395048 |
| 37 | PDGFRB | 1.21290915 |
| 38 | MAP3K7 | 1.20323004 |
| 39 | PIK3CA | 1.17916115 |
| 40 | CCNB1 | 1.16331942 |
| 41 | CDK12 | 1.13878297 |
| 42 | LMTK2 | 1.13864480 |
| 43 | SGK494 | 1.12907420 |
| 44 | SGK223 | 1.12907420 |
| 45 | TGFBR2 | 1.10468775 |
| 46 | EPHB1 | 1.08382222 |
| 47 | ERBB2 | 1.07884999 |
| 48 | DYRK1B | 1.04157190 |
| 49 | PNCK | 1.02575552 |
| 50 | MOS | 1.01214091 |
| 51 | SIK1 | 1.00567386 |
| 52 | KDR | 1.00058305 |
| 53 | NME1 | 0.97817263 |
| 54 | PAK2 | 0.95218979 |
| 55 | PKN2 | 0.94365625 |
| 56 | MAPK15 | 0.90822189 |
| 57 | DDR2 | 0.89939257 |
| 58 | FER | 0.89189702 |
| 59 | AKT2 | 0.88500996 |
| 60 | PTK6 | 0.88476530 |
| 61 | ROCK1 | 0.88411281 |
| 62 | TESK1 | 0.86577828 |
| 63 | PRKD1 | 0.86334359 |
| 64 | PRKCH | 0.83637963 |
| 65 | STK3 | 0.81733740 |
| 66 | PAK3 | 0.80461465 |
| 67 | NEK9 | 0.80457492 |
| 68 | ADRBK1 | 0.78847154 |
| 69 | STK38 | 0.78206587 |
| 70 | RET | 0.78149109 |
| 71 | ERBB3 | 0.76689247 |
| 72 | NUAK1 | 0.75752286 |
| 73 | PBK | 0.74518089 |
| 74 | GSK3A | 0.71004934 |
| 75 | BRD4 | 0.67886902 |
| 76 | MAPK12 | 0.66729378 |
| 77 | CAMK2G | 0.66557729 |
| 78 | MET | 0.66480030 |
| 79 | PRKD2 | 0.65616772 |
| 80 | BRSK2 | 0.65520377 |
| 81 | BMPR1B | 0.64376812 |
| 82 | EIF2AK3 | 0.63130065 |
| 83 | MTOR | 0.63114183 |
| 84 | MARK3 | 0.63014152 |
| 85 | MAP2K3 | 0.61816187 |
| 86 | LIMK1 | 0.61622092 |
| 87 | STK38L | 0.61367658 |
| 88 | TGFBR1 | 0.60893205 |
| 89 | PRKAA2 | 0.60877197 |
| 90 | MAP2K1 | 0.60054305 |
| 91 | CDK9 | 0.59898074 |
| 92 | CDC42BPA | 0.59680227 |
| 93 | PAK6 | 0.58520333 |
| 94 | MAP3K4 | 0.57970466 |
| 95 | RPS6KB2 | 0.57812773 |
| 96 | MAPK7 | 0.57496465 |
| 97 | FGFR1 | 0.56344811 |
| 98 | PTK2 | 0.55584262 |
| 99 | PRKAA1 | 0.55542362 |
| 100 | PLK4 | 0.54174909 |
| 101 | EPHA3 | 0.53111291 |
| 102 | CSNK1D | 0.52574269 |
| 103 | WEE1 | 0.51240332 |
| 104 | INSRR | 0.49211749 |
| 105 | AKT3 | 0.49047407 |
| 106 | PAK4 | 0.46099990 |
| 107 | LATS2 | 0.45113251 |
| 108 | NEK2 | 0.45081116 |
| 109 | OXSR1 | 0.44211155 |
| 110 | PKN1 | 0.43821494 |
| 111 | ERBB4 | 0.43296327 |
| 112 | PRKG1 | 0.43199349 |
| 113 | MAPK11 | 0.42000141 |
| 114 | MAPK4 | 0.41042032 |
| 115 | TLK1 | 0.40465090 |
| 116 | ZAK | 0.40425769 |
| 117 | UHMK1 | 0.39913008 |
| 118 | STK16 | 0.39607033 |
| 119 | SGK3 | 0.39052736 |
| 120 | HIPK2 | 0.38876280 |
| 121 | NEK6 | 0.38604826 |
| 122 | ILK | 0.37581338 |
| 123 | PRKACB | 0.36968966 |
| 124 | CAMK4 | 0.36424943 |
| 125 | RPS6KA3 | 0.36096542 |
| 126 | RAF1 | 0.35699632 |
| 127 | CDK8 | 0.35207361 |
| 128 | PDPK1 | 0.34134242 |
| 129 | MARK2 | 0.33755383 |
| 130 | ROCK2 | 0.33738541 |
| 131 | ABL2 | 0.33474854 |
| 132 | ARAF | 0.32715513 |
| 133 | SGK2 | 0.32475718 |
| 134 | CAMK2D | 0.32072723 |
| 135 | GSK3B | 0.31580324 |
| 136 | AURKB | 0.30520064 |
| 137 | DYRK1A | 0.29613609 |
| 138 | MKNK1 | 0.29469476 |
| 139 | SRC | 0.29052425 |
| 140 | WNK3 | 0.28297972 |
| 141 | MAPKAPK5 | 0.28191792 |
| 142 | IRAK1 | 0.28061213 |
| 143 | DAPK3 | 0.25410314 |
| 144 | CAMK2A | 0.25137037 |
| 145 | FRK | 0.24197129 |
| 146 | RPS6KB1 | 0.23393314 |
| 147 | MAP2K4 | 0.22985768 |
| 148 | PRKACA | 0.22622907 |
| 149 | CAMK1 | 0.21610334 |
| 150 | NLK | 0.21521515 |
| 151 | RPS6KA5 | 0.21322624 |
| 152 | KSR2 | 0.20229147 |
| 153 | MAPK10 | 0.19242582 |
| 154 | PAK1 | 0.19183023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39479188 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32320163 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.32276308 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 11.4656085 |
| 5 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.99917344 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.85294684 |
| 7 | Carbon metabolism_Homo sapiens_hsa01200 | 1.76156049 |
| 8 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.62771270 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60178515 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54582737 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.49082207 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48201988 |
| 13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.41061767 |
| 14 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40434383 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.40297065 |
| 16 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.39772828 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39204196 |
| 18 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.29576652 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27305819 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26591810 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24814778 |
| 22 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.24185542 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.17617887 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13518514 |
| 25 | Tight junction_Homo sapiens_hsa04530 | 1.11162700 |
| 26 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.07599813 |
| 27 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.07114758 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.06925300 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.05780447 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04694516 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04619672 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.01019287 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97480989 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95966270 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94787161 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93980247 |
| 37 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93670677 |
| 38 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90758524 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90599307 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89891059 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89885013 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89119955 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87701120 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86966746 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86888562 |
| 46 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85681195 |
| 47 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85476371 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85128309 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84849012 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82921005 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82698842 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82619961 |
| 53 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81458552 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81125703 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80030500 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78018955 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77799576 |
| 58 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.77367800 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76590900 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75725260 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74622225 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73443350 |
| 63 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73072224 |
| 64 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72930057 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.72767373 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71375173 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.71049764 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70649003 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70532453 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70431347 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70246685 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.70197401 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69962944 |
| 74 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69493963 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69096687 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.68940425 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68010684 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67954353 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.66851416 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66514857 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65611432 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65282014 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.64481103 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63019143 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61865717 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61405566 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60860250 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60432790 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58785361 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.57391503 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57049545 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56845178 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56792361 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56225511 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56026903 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55962391 |
| 97 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55781204 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55678277 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54675689 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54425952 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.54018571 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.53657218 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53153044 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52701778 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52467147 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52031466 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50383325 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50147205 |
| 109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49459419 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48578300 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48388831 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48324835 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48026801 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47485417 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.47098584 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46481319 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45862493 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45230559 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45137044 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44682464 |
| 121 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44344383 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43649118 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43345148 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43035527 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42976518 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41543726 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40705321 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39966865 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.39535144 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39345749 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38225368 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38212802 |
| 133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37947222 |
| 134 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37743487 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37498071 |
| 136 | Salivary secretion_Homo sapiens_hsa04970 | 0.36904697 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36842210 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.36746260 |
| 139 | Alcoholism_Homo sapiens_hsa05034 | 0.36535255 |
| 140 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32529923 |
| 141 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.29681086 |
| 142 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28503542 |
| 143 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26394231 |

